array(2) { ["lab"]=> string(4) "1347" ["publication"]=> string(5) "11781" } A Novel Linc00308/D21S2088E Intergenic Region ALK Fusion and Its Enduring Clinical Responses to Crizotinib - 肿瘤精准医学与个性化用药研究团队 | LabXing

肿瘤精准医学与个性化用药研究团队

简介

分享到

A Novel Linc00308/D21S2088E Intergenic Region ALK Fusion and Its Enduring Clinical Responses to Crizotinib

2020
期刊 Journal of Thoracic Oncology
下载全文